In July, the U.S. House of Representatives opened hearings and introduced legislation to address the issue of surprise billing entitled the “No Surprises Act” (H.R. 3630). By July 17, the legislation had been subject to mark-up and amendments as well in the House Energy and Commerce Committee, which reported out the proposed legislation to the...
On June 25, the White House announced an initiative to encourage greater transparency in drug pricing. President Trump signed an Executive Order on June 25, entitled “Improving Price and Quality Transparency in American Healthcare to Put Patients First.” The purpose of the order is to direct federal agencies to issue regulations to improve the transparency...
ISASS’ Coding and Reimbursement Task Force is undertaking drafts of policy statements on two new spine technologies, the Intracept procedure for Basivertebral nerve treatment, and the Barricaid implant for annular closure. These technologies are among the newest and most promising treatments for vertebral conditions and likely to increase in dissemination and use by practitioners. The...
On June 18, a key Senate committee held hearings and says it is ready to start marking up a bill next week designed to contain healthcare costs. The wide-ranging legislative package on curbing healthcare costs is sponsored by Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.), the chairman and ranking member of the Health, Education,...